Literature DB >> 6874957

Defective adenosine triphosphate synthesis. An explanation for skeletal muscle dysfunction in phosphate-deficient mice.

B D Hettleman, R L Sabina, M K Drezner, E W Holmes, J L Swain.   

Abstract

The basis for skeletal muscle dysfunction in phosphate-deficient patients and animals is not known, but it is hypothesized that intracellular phosphate deficiency leads to a defect in ATP synthesis. To test this hypothesis, changes in muscle function and nucleotide metabolism were studied in an animal model of hypophosphatemia. Mice were made hypophosphatemic through restriction of dietary phosphate intake. Gastrocnemius function was assessed in situ by recording isometric tension developed after stimulation of the nerve innervating this muscle. Changes in purine nucleotide, nucleoside, and base content of the muscle were quantitated at several time points during stimulation and recovery. Serum concentration and skeletal muscle content of phosphorous are reduced by 55 and 45%, respectively, in the dietary restricted animals. The gastrocnemius muscle of the phosphate-deficient mice fatigues more rapidly compared with control mice. ATP and creatine phosphate content fall to a comparable extent during fatigue in the muscle from both groups of animals; AMP, inosine, and hypoxanthine (indices of ATP catabolism) appear in higher concentration in the muscle of phosphate-deficient animals. Since total ATP use in contracting muscle is closely linked to total developed tension, we conclude that the comparable drop in ATP content in association with a more rapid loss of tension is best explained by a slower rate of ATP synthesis in the muscle of phosphate-deficient animals. During the period of recovery after muscle stimulation, ATP use for contraction is minimal, since the muscle is at rest. In the recovery period, ATP content returns to resting levels more slowly in the phosphate-deficient than in the control animals. In association with the slower rate of ATP repletion, the precursors inosine monophosphate and AMP remain elevated for a longer period of time in the muscle of phosphate-deficient animals. The slower rate of ATP repletion correlates with delayed return of normal muscle contractility in the phosphate-deficient mice. These studies suggest that the slower rate of repletion of the ATP pool may be the consequence of a slower rate of ATP synthesis and this is in part responsible for the delayed recovery of normal muscle contractility.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874957      PMCID: PMC1129216          DOI: 10.1172/JCI111006

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  The muscle cell in chronic alcoholism: the possible role of phosphate depletion in alcoholic myopathy.

Authors:  J P Knochel; G L Bilbrey; T J Fuller; N W Carter
Journal:  Ann N Y Acad Sci       Date:  1975-04-25       Impact factor: 5.691

2.  Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation.

Authors:  S E Silvis; P D Paragas
Journal:  Gastroenterology       Date:  1972-04       Impact factor: 22.682

3.  Metabolic profiles of three fiber types of skeletal muscle in guinea pigs and rabbits.

Authors:  J B Peter; R J Barnard; V R Edgerton; C A Gillespie; K E Stempel
Journal:  Biochemistry       Date:  1972-07-04       Impact factor: 3.162

4.  Hemolytic anemia and somatic cell dysfunction in severe hypophosphatemia.

Authors:  J C Klock; H E Williams; W C Mentzer
Journal:  Arch Intern Med       Date:  1974-08

5.  Acute hemolytic anemia with rigid red cells in hypophosphatemia.

Authors:  H S Jacob; T Amsden
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

6.  Evidence for a phosphorus-depletion syndrome in man.

Authors:  M Lotz; E Zisman; F C Bartter
Journal:  N Engl J Med       Date:  1968-02-22       Impact factor: 91.245

7.  The effect of 2,4-dinitrofluorobenzene on the activity of striated muscle.

Authors:  A A Infante; R E Davies
Journal:  J Biol Chem       Date:  1965-10       Impact factor: 5.157

8.  Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation.

Authors:  P R Craddock; Y Yawata; L VanSanten; S Gilberstadt; S Silvis; H S Jacob
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

9.  Alterations of red-cell glycolytic intermediates and oxygen transport as a consequence of hypophosphatemia in patients receiving intravenous hyperalimentation.

Authors:  S F Travis; H J Sugerman; R L Ruberg; S J Dudrick; M Delivoria-Papadopoulos; L D Miller; F A Oski
Journal:  N Engl J Med       Date:  1971-09-30       Impact factor: 91.245

10.  Reduced red cell glycolysis, 2, 3-diphosphoglycerate and adenosine triphosphate concentration, and increased hemoglobin-oxygen affinity caused by hypophosphatemia.

Authors:  M A Lichtman; D R Miller; J Cohen; C Waterhouse
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

View more
  14 in total

Review 1.  Hereditary disorders of renal phosphate wasting.

Authors:  Amir S Alizadeh Naderi; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2010-10-05       Impact factor: 28.314

2.  Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia.

Authors:  Otmane Nafidi; Real W Lapointe; Raymond Lepage; Rajiv Kumar; Pierre D'Amour
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

3.  Effects of transgenic Pit-1 overexpression on calcium phosphate and bone metabolism.

Authors:  Atsushi Suzuki; Patrick Ammann; Keiko Nishiwaki-Yasuda; Sahoko Sekiguchi; Shogo Asano; Shizuko Nagao; Ryosuke Kaneko; Masumi Hirabayashi; Yutaka Oiso; Mitsuyasu Itoh; Joseph Caverzasio
Journal:  J Bone Miner Metab       Date:  2009-10-01       Impact factor: 2.626

Review 4.  A unified model for bone-renal mineral and energy metabolism.

Authors:  Peter S Rowe
Journal:  Curr Opin Pharmacol       Date:  2015-04-13       Impact factor: 5.547

5.  Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction.

Authors:  J L Swain; J J Hines; R L Sabina; O L Harbury; E W Holmes
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  Hypophosphatemia induced by dietary aluminium hydroxide supplementation in growing pigs: effects on erythrocytes, myocardium, skeletal muscle and liver.

Authors:  L Håglin; B Essén-Gustavsson; A Lindholm
Journal:  Acta Vet Scand       Date:  1994       Impact factor: 1.695

7.  Adenosine triphosphate turnover in humans. Decreased degradation during relative hyperphosphatemia.

Authors:  M A Johnson; K Tekkanat; S P Schmaltz; I H Fox
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

8.  Effect of hypophosphatemia on muscle metabolism after exercise in pigs.

Authors:  L Håglin; B Essén-Gustavsson
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

9.  Skeletal Muscle, but not Cardiovascular Function, Is Altered in a Mouse Model of Autosomal Recessive Hypophosphatemic Rickets.

Authors:  Michael J Wacker; Chad D Touchberry; Neerupma Silswal; Leticia Brotto; Chris J Elmore; Lynda F Bonewald; Jon Andresen; Marco Brotto
Journal:  Front Physiol       Date:  2016-05-13       Impact factor: 4.566

10.  PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism.

Authors:  Lesya V Zelenchuk; Anne-Marie Hedge; Peter S N Rowe
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.